BioActive Biologics Signs Letter of Intent with Neptunus Biotech for Strategic Investment

DELAWARE, March 25, 2025 – BioActive Biologics, a pioneer in innovative agricultural inputs, is pleased to announce the signing of a Letter of Intent (LOI) for an initial investment and potential merger with Neptunus Biotech, a UK-based company.

This strategic alliance marks a key milestone in BioActive Biologics' mission to expand globally and diversify its portfolio of sustainable agricultural solutions through organic growth and synergistic acquisitions.

Neptunus Biotech, with a strong presence in Mexico, Central and South America, and the Caribbean, is a leading developer of microalgae-based biostimulants. Its groundbreaking work aligns with BioActive Biologics' commitment to delivering cost-effective, high-performance biostimulants, biopesticides, and biocontrol products that enhance crop yields, improve nutrient value, and restore soil health—offering significant benefits to farmers worldwide.

The agreement, subject to the completion of concurrent financing and the attainment of key milestones, reflects a shared vision to leverage both companies’ expertise and resources to drive innovation in global agriculture as the industry shifts from chemical inputs to biological solutions.

For more information about Neptunus Biotech, visit https://www.neptunusbiotech.com/empresa.html.